Pretravel preparation and travel-related morbidity in patients with inflammatory bowel disease

Symptoms of Infectious Diseases in Immunocompromised Travelers: A Prospective Study With Matched Controls

(2011) Gijs G. Baaten et al.   JOURNAL OF TRAVEL MEDICINE

An Inactivated Cell-Culture Vaccine against Yellow Fever

(2011) Thomas P. Monath et al.   NEW ENGLAND JOURNAL OF MEDICINE

A Practical Guide to Vaccinating the Inflammatory Bowel Disease Patient

(2010) Sharmeel K Wasan et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections

(2009) S. SCHNEEWEISS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Immunizations in patients with inflammatory bowel disease

(2009) Ying Lu et al.   INFLAMMATORY BOWEL DISEASES

European evidence-based Consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease

(2009) J.F. Rahier et al.   Journal of Crohns & Colitis

Comparison of Interferon-Gamma Release AssayVersusTuberculin Skin Test for Tuberculosis Screening in Inflammatory Bowel Disease

(2008) Alain M. Schoepfer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Yellow fever vaccine: past, present and future

(2008) Anna H Roukens et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Risk Factors for Opportunistic Infections in Patients With Inflammatory Bowel Disease

(2008) Murat Toruner et al.   GASTROENTEROLOGY

Long-term safety of infliximab for the treatment of inflammatory bowel disease: a single-centre cohort study

(2008) H Fidder et al.   GUT

Salmonella infections in immunocompromised adults

(2008) Melita A. Gordon   JOURNAL OF INFECTION